Scopolamine Transdermal Therapeutic System — Class II drug recall D-0816-2018
Terminated recall by L. Perrigo Company, reported 2018-05-23, distributed nationwide. Defective delivery system
| Recall number | D-0816-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | L. Perrigo Company, Allegan, MI, United States |
| Recall initiated | 2018-05-11 |
| Classified | 2018-05-15 |
| Reported by FDA | 2018-05-23 |
| Terminated | 2020-09-28 |
| Distributed | Nationwide (US) |
| Quantity | 569,520 cartons |
| NDC | 45802-0580, 45802-0580-01, 45802-0580-46, 45802-0580-62, 45802-0580-84 |
Product
Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46); c) 24-count (NDC 45802-580-62), Rx only, Mfd. by: Aveva Drug Delivery Systems, A Nitto Denko Company, Miramar, FL 33025 Distributed by Perrigo, Allegan, MI 49010
Reason for recall
Defective delivery system
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0816-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.